4.6 Article

PF-4708671 Activates AMPK Independently of p70S6K1 Inhibition

Journal

PLOS ONE
Volume 9, Issue 9, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0107364

Keywords

-

Funding

  1. Tel-Aviv Sourasky Medical Center
  2. Israeli Ministry of Health [5938]
  3. Israeli Cancer Association
  4. Israeli Science Foundation (ISF) [1462]

Ask authors/readers for more resources

The P70 ribosomal protein S6 kinase 1 (P70S6K1) is activated by the mammalian target of rapamycin (mTORC1) and regulates proliferation, growth, and metabolism. PF-4708671 is a novel, cell-permeable, has been proposed to be a highly specific inhibitor of p70S6K1. It is used in micromolar concentration range to dissect signaling pathways downstream of mTORC1 and to study the function of p70S6K1. Here we show that PF-4708671 induces AMP-activated protein kinase (AMPK) phosphorylation and activation in immortalized mouse embryonic fibroblasts (MEF) independently of p70S6K1, due to specific inhibition of mitochondrial respiratory chain Complex I.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Infantile SOD1 deficiency syndrome caused by a homozygous SOD1 variant with absence of enzyme activity

Shlomit Ezer, Muhannad Daana, Julien H. Park, Shira Yanovsky-Dagan, Ulrika Nordstrom, Adily Basal, Simon Edvardson, Ann Saada, Markus Otto, Vardiella Meiner, Stefan L. Marklund, Peter Munch Andersen, Tamar Harel

Summary: Pathogenic variants in the SOD1 gene are associated with a severe motor-neurological syndrome in infants, characterized by global developmental delay and movement impairments. This study identified a homozygous loss-of-function variant in the SOD1 gene in an infant with severe neurological symptoms. Further analysis showed that this variant leads to instability and degeneration of the SOD1 protein. The study highlights the importance of specific valine residues in the SOD1 protein and suggests implications for future therapeutic research.

BRAIN (2022)

Article Oncology

A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy

Tammi Arbel Rubinstein, Inbal Reuveni, Arkadi Hesin, Anat Klein-Goldberg, Hannes Olauson, Tobias E. Larsson, Carmela R. Abraham, Ella Zeldich, Assumpcio Bosch, Miguel Chillon, Kenneth Samuel Hollander, Ayelet Shabtay-Orbach, Gilad W. Vainer, Ido Wolf, Tami Rubinek

Summary: The study demonstrated that klotho acts as a tumor suppressor in pancreatic ductal adenocarcinoma, with DNA methylation being correlated with patient survival. The findings suggest that sKL could serve as a therapeutic agent for pancreatic cancer.

CANCERS (2021)

Article Cell Biology

Multifaceted Analyses of Isolated Mitochondria Establish the Anticancer Drug 2-Hydroxyoleic Acid as an Inhibitor of Substrate Oxidation and an Activator of Complex IV-Dependent State 3 Respiration

Kumudesh Mishra, Maria Peter, Anna Maria Nardiello, Guy Keller, Victoria Llado, Paula Fernandez-Garcia, Ulf D. Kahlert, Dinorah Barasch, Ann Saada, Zsolt Toeroek, Gabor Balogh, Pablo V. Escriba, Stefano Piotto, Or Kakhlon

Summary: The synthetic fatty acid 2-hydroxyoleic acid (2OHOA) has been investigated for its potential as a cancer therapy. It has been found to regulate membrane lipid composition and structure, and can uncouple oxidative phosphorylation. This study explores the effects of 2OHOA on mitochondria and shows that it hydroxylates mitochondrial lipids, leading to decreased co-enzyme Q diffusion and inhibition of respiratory complex activity.

CELLS (2022)

Article Health Care Sciences & Services

Identifying the Steps Required to Effectively Implement Next-Generation Sequencing in Oncology at a National Level in Europe

Denis Horgan, Giuseppe Curigliano, Olaf Riess, Paul Hofman, Reinhard Buettner, Pierfranco Conte, Tanja Cufer, William M. Gallagher, Nadia Georges, Keith Kerr, Frederique Penault-Llorca, Ken Mastris, Carla Pinto, Jan Van Meerbeeck, Elisabetta Munzone, Marlene Thomas, Sonia Ujupan, Gilad W. Vainer, Janna-Lisa Velthaus, Fabrice Andre

Summary: Next-generation sequencing (NGS) has the potential to revolutionize cancer treatment with its personalized approach. However, the implementation of NGS in Europe varies, highlighting the need for collaboration among stakeholders. To address this issue, the European Alliance for Personalised Medicine (EAPM) established expert panels consisting of key stakeholders from 10 European countries. The panels identified challenges related to NGS demand and supply, and made recommendations for multi-stakeholder collaboration to improve patient care.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Article Genetics & Heredity

What Can We Learn from the Parents of Children Affected with Mucopolysaccharidosis Type III-A in Israel?

Shiri Liber, Orna Staretz-Chacham, Mor Kishon, Ben Pode-Shakked, Odelia Chorin, Katya Kneller, Yair Anikster, Geto Mangisto, Ann Saada, Annick Raas-Rothschild

Summary: Sanfilippo Syndrome is a lysosomal storage disorder caused by enzyme deficiency leading to tissue accumulation of heparan sulfate. It is characterized by progressive neurodegeneration and systemic manifestations. Delayed diagnosis is common, and early clinical features include speech delay, coarse facial features, and global developmental delay.

MOLECULAR SYNDROMOLOGY (2022)

Article Biochemistry & Molecular Biology

Replicative Stress Coincides with Impaired Nuclear DNA Damage Response in COX4-1 Deficiency

Liza Douiev, Chaya Miller, Guy Keller, Hadar Benyamini, Bassam Abu-Libdeh, Ann Saada

Summary: In this study, we demonstrated that COX4-1 deficiency leads to accumulative DNA damage and premature cellular senescence.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cell Biology

Cytochrome c Oxidase Activity as a Metabolic Regulator in Pancreatic Beta-Cells

Genya Aharon-Hananel, Leonor Romero-Afrima, Ann Saada, Carmit Mantzur, Itamar Raz, Sarah Weksler-Zangen

Summary: The pancreatic beta-cells in Cohen diabetic-sensitive (CDs) rats exhibit decreased COX activity which correlates with reduced GSIS and increased blood glucose levels, leading to hyperglycemia when COX activity drops below 46%, but can be restored by a reversion diet. Interestingly, there is a significant correlation between COX activity in peripheral-blood mononuclear cells (PBMCs) and islets, showing potential as a noninvasive biomarker for beta-cell dysfunction monitoring in diabetes.

CELLS (2022)

Article Biochemistry & Molecular Biology

Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects

Madleen Zighan, David Arkadir, Liza Douiev, Guy Keller, Chaya Miller, Ann Saada

Summary: Omaveloxolone, a second-generation triterpenoid Nrf2 inducer, has antioxidant and anti-inflammatory properties. It has the potential to improve mitochondrial bioenergetics and could be beneficial for disorders involving mitochondrial dysfunction. In this study, Omaveloxolone was found to have effects on primary fibroblasts derived from patients with mitochondrial complex I deficiency, mitochondrial cytochrome oxidase deficiency, and recessive Parkinson's disease. However, further investigation is needed to explore its precise effects on mitochondrial function in these diseases.

FRONTIERS IN MOLECULAR BIOSCIENCES (2022)

Article Biochemical Research Methods

Comparison of matched formalin-fixed paraffin embedded and fresh frozen meningioma tissue reveals bias in proteomic profiles

Hanan Schoffman, Yishai Levin, Ayelet Itzhaki-Alfia, Lea Tselekovits, Lior Gonen, Gilad Wolf Vainer, Goni Hout-Siloni, Iris Barshack, Zvi R. Cohen, Nevo Margalit, Tal Shahar

Summary: This study compared the effects of formaldehyde-fixed paraffin-embedded (FFPE) tissue blocks and fresh frozen tissue (FFT) on the quantifiable proteome. The results showed that both methods yield a similar number of proteins, but there are significant differences in the proteome composition, with FFPE specimens enriched with smaller proteins.

PROTEOMICS (2022)

Article Endocrinology & Metabolism

Addition of galactose-1-phosphate measurement enhances newborn screening for classical galactosemia

Suha Daas, Nasser Abu Salah, Yair Anikster, Ortal Barel, Nadirah S. Damseh, Elena Dumin, Aviva Fattal-Valevski, Tzipora C. Falik-Zaccai, Clair Habib, Sagi Josefsberg, Stanley H. Korman, Katya Kneller, Yuval Landau, Tally Lerman-Sagie, Hanna Mandel, Yehoshua Manor, Tameemi Moady Abdalla, Rachel Rock, Nira Rostami, Ann Saada, Talya Saraf-Levy, Nava Shaul Lotan, Ronen Spiegel, Orna Staretz-Chacham, Galit Tal, Igor Ulanovsky, Taly Vaisid, Yael Wilnai, Shlomo Almashanu

Summary: Galactosemia is an inborn disorder of carbohydrate metabolism. Israeli newborn screening algorithm for galactosemia includes measurement of galactose-1-phosphate as the first-tier screening test and GALT enzyme activity as the second-tier test.

JOURNAL OF INHERITED METABOLIC DISEASE (2023)

Article Biochemistry & Molecular Biology

Mitochondrial-derived vesicles retain membrane potential and contain a functional ATP synthase

Reut Hazan (Ben-Menachem), Dvora Lintzer, Tamar Ziv, Koyeli Das, Irit Rosenhek-Goldian, Ziv Porat, Hila Ben Ami Pilo, Sharon Karniely, Ann Saada, Neta Regev-Rudzki, Ophry Pines

Summary: Vesicular transport is a means of communication between cells, and this study focuses on organelle-to-organelle communication, specifically between mitochondria. The researchers discovered that functional mitochondria in yeast can release vesicles, which are about 100 nm in size and carry selective protein cargo, including ATP synthase subunits. These vesicles also contain a functional ATP synthase complex and have the ability to fuse with naive mitochondria, potentially delivering ATP and participating in organelle-to-organelle communication.

EMBO REPORTS (2023)

Article Multidisciplinary Sciences

Equivalence of laboratory-developed test and PD-L1 IHC 22C3 pharmDx across all combined positive score indications

Gilad Vainer, Lingkang Huang, Kenneth Emancipator, Shanthy Nuti

Summary: We analyzed the concordance of a laboratory-developed test (LDT) based on the 22C3 antibody with the regulatory-approved PD-L1 IHC 22C3 pharmDx in multiple tumor types. The LDT showed high agreement with the pharmDx in terms of negative percentage agreement (NPA), positive percentage agreement (PPA), and overall percentage agreement (OPA) across all tumor types. The findings suggest the comparability of the LDT with the regulatory-approved pharmDx.

PLOS ONE (2023)

Article Oncology

Early Infi ltration of Innate Immune Cells to the Liver Depletes HNF4 & alpha; andPromotes Extrahepatic Carcinogenesis

Omer Goldman, Lital N. Adler, Emma Hajaj, Tommaso Croese, Naama Darzi, Sivan Galai, Hila Tishler, Yarden Ariav, Dor Lavie, Liat Fellus-Alyagor, Roni Oren, Yuri Kuznetsov, Eyal David, Rami Jaschek, Chani Stossel, Oded Singer, Sergey Malitsky, Renana Barak, Rony Seger, Neta Erez, Ido Amit, Amos Tanay, Ann Saada, Talia Golan, Tamar Rubinek, Joo Sang Lee, Shay Ben-Shachar, Ido Wolf, Ayelet Erez

Summary: Multiple studies have found metabolic changes within the tumor and its micro-environment during carcinogenesis, but the mechanisms by which tumors affect the host metabolism are unclear. This study discovered that systemic inflammation induced by cancer results in the infiltration of myeloid cells into the liver, leading to the depletion of a master metabolic regulator, HNF4α, and subsequently causing systemic metabolic changes that promote breast and pancreatic cancer proliferation.

CANCER DISCOVERY (2023)

Article Cell Biology

The Beneficial Effect of Mitochondrial Transfer Therapy in 5XFAD Mice via Liver-Serum-Brain Response

Sahar Sweetat, Keren Nitzan, Nir Suissa, Yael Haimovich, Michal Lichtenstein, Samar Zabit, Sandrine Benhamron, Karameh Akarieh, Kumudesh Mishra, Dinorah Barasch, Ann Saada, Tamar Ziv, Or Kakhlon, Haya Lorberboum-Galski, Hanna Rosenmann

Summary: We investigated the efficacy of mitochondrial transfer in 5XFAD transgenic mice and found that it improved cognitive impairment, reduced amyloid burden, and alleviated mitochondrial dysfunction. The exogenously injected mitochondria were detected in the liver, but not in the brain. We observed changes in the brain proteome and liver metabolome, suggesting that the beneficial effects of mitochondrial transfer may be mediated by metabolic signaling from the liver to the brain via the serum. These findings highlight the potential of mitochondrial transfer as a novel therapy for Alzheimer's disease.

CELLS (2023)

Meeting Abstract Biochemistry & Molecular Biology

PRKN exon inversion leads to juvenile generalized levodopa-responsive dystonia

Emuna Paz, Hagar Mor-Shaked, Adily Basal, Simona Ben-Haim, Hanna Grobe, Sami Heymann, Zvi Israel, Vardiella Meiner, Montaser Namnah, Anat Nitzan, Ann Saada, Tomer Tzur, Ronen Zaidel-Bar, Tamar Harel, David Arkadir

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

No Data Available